Search All News
In people with dementia, delirium during COVID-19 is more common but deaths from COVID-19 are not disproportionately higher, finds a new study.
New research may lead to the development of drugs to prevent the nerve damage and pain many cancer patients experience during chemotherapy.
Cells used to study the human blood-brain barrier in the lab aren’t what they seem, a new study has found, throwing nearly a decade’s worth of research into question.
A new Columbia study suggests that malfunctioning endosomes—a central trafficking station inside neurons—are commonly involved in the appearance of Alzheimer’s disease.
- December 21, 2015
Increased connectivity in the brain's default mode network is a potential precursor, or biomarker, indicating a risk of developing major depressive disorder.
- December 21, 2015
A drug that boosts activity in the brain’s “garbage disposal” system can decrease levels of toxic proteins associated with Alzheimer’s disease.
- December 9, 2015
P&S researcher Wendy Chung and colleagues find genetic mutations that explain why many children with congenital heart disease also have neurodevelopmental disorders.
- November 24, 2015
A new study of Alzheimer's in people with Down Syndrome may lead to tests that detect Alzheimer's early.
- November 23, 2015
A study provides new insights into the development of mood disorders and may aid in designing improved therapies.
- October 22, 2015
In a case demonstrating the promise of precision medicine, a 20-month-old girl suffering from a rare neurodegenerative disease was diagnosed by exome sequencing and successfully treated.
- October 5, 2015
Wendy Chung is part of a team that found commonalities in neuronal behavior between spinal muscular atrophy and ALS.
- October 2, 2015
Funding from the ALS Association and the Tow Foundation will be used by the New York Genome Center to determine the entire genetic sequence of people with ALS who donated their tissues after death.